Apheresis unit
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
17-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Fresenius Kabi Australia Pty Ltd
Class:
Class IIb
Manufactured by:
Fresenius Kabi AG 61346, Bad Homburg Germany
Therapeutic area:
16405 - Apheresis unit
Therapeutic indications:
Used to separate whole blood collected during an operation into its components, wash these components and return some or all of them to the patient.
Authorization status:
A
Authorization date:
2007-12-19
